Multi-centre trial of naproxen and phenylbutazone in acute gout.
作者信息
Sturge R A, Scott J T, Hamilton E B, Liyanage S P, Dixon S T, Engler C
出版信息
Adv Exp Med Biol. 1977;76B:290-6. doi: 10.1007/978-1-4684-3285-5_44.
PMID:857623
Abstract
Naproxen 750 mg as a single dose followed by 250 mg three times daily has been compared with phenylbutazone 200 mg four times daily for 48 hours followed by 200 mg three times daily for the treatment of acute gout in an open study on 41 patients. The drugs were equally effective with few and relatively mild side effects. Naproxen is a useful alternative agent for the treatment of acute gout.
摘要
相似文献
1
Multi-centre trial of naproxen and phenylbutazone in acute gout.
Adv Exp Med Biol. 1977;76B:290-6. doi: 10.1007/978-1-4684-3285-5_44.
2
Multicentre trial of naproxen and phenylbutazone in acute gout.萘普生和保泰松治疗急性痛风的多中心试验。
Ann Rheum Dis. 1977 Feb;36(1):80-2. doi: 10.1136/ard.36.1.80.
3
[Pharmacotherapy in uratic arthritis. I].
Tidsskr Nor Laegeforen. 1977 May 10;97(13):656.
4
The treatment of acute gout with naproxen.
J Clin Pharmacol. 1975 Apr;15(4 Pt. 2):363-6. doi: 10.1002/j.1552-4604.1975.tb01465.x.
5
Chemistry and pharmacology of naproxen.萘普生的化学与药理学
Arzneimittelforschung. 1975 Feb;25(2A):278-81.
6
[Methoxypropriocin in the treatment of gout].
Wiad Lek. 1976 Oct 15;29(20):1791-3.
7
Clinical and objective assessments of naproxen through 5 years of clinical experience.通过5年临床经验对萘普生进行的临床和客观评估。
Arzneimittelforschung. 1975 Feb;25(2A):327-32.
8
A double-blind, multi-centre comparison of naproxen and indomethacin in acute musculo-skeletal disorders.萘普生与吲哚美辛治疗急性肌肉骨骼疾病的双盲、多中心比较
Curr Med Res Opin. 1976;4(5):373-80. doi: 10.1185/03007997609109332.
9
[Observations of long-term treatment of arthrosis with naproxen].
Arzneimittelforschung. 1975 Feb;25(2A):325-7.
10
Double-blind trial of flurbiprofen and phenylbutazone in acute gouty arthritis.氟比洛芬与保泰松治疗急性痛风性关节炎的双盲试验
Br J Clin Pharmacol. 1985 Nov;20(5):511-3. doi: 10.1111/j.1365-2125.1985.tb05110.x.
引用本文的文献
1
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).欧洲抗风湿病联盟关于痛风的循证推荐意见。第二部分：管理。欧洲抗风湿病联盟国际临床研究包括治疗学常务委员会（ESCISIT）特别工作组报告
Ann Rheum Dis. 2006 Oct;65(10):1312-24. doi: 10.1136/ard.2006.055269. Epub 2006 May 17.
Zotero 插件